| Literature DB >> 30978173 |
Dong Liu1,2, Zhiwei Yin1, Qi Huang1,3, Yi Ren1, Diangeng Li1, Linna Wang1, Shaoyuan Cui1, Ying Zhang1, Yichun Ning1,4, Lide Lun2, Guangyan Cai1, Xueyuan Bai1, Xuefeng Sun1, Xiangmei Chen1.
Abstract
We established an exogenous biological renal support model through the generation of parabiotic mice. At 72 hours after ischemia reperfusion injury (IRI), the aged mice that received exogenous biological renal support showed significantly higher levels of renal cell proliferation and dedifferentiation, lower levels of renal tubular injury, improved renal function, and a lower mortality than those that did not receive exogenous biological renal support. Using the Quantibody Mouse Cytokine Antibody Array, we found that aged IRI mice that received exogenous biological renal support had an up-regulation of multiple inflammatory related cytokines compared to the group that did not receive exogenous biological renal support. We suggest that the exogenous biological renal support might promote renal tubular epithelial cell proliferation and dedifferentiation and improve the prognosis of aged IRI mice. Exogenous biological renal support may play an important role in the amelioration of renal IRI by regulating the expression of multiple cytokines.Entities:
Keywords: aged; cytokines; exogenous biological renal support; parabiosis model; renal ischemia reperfusion injury
Mesh:
Substances:
Year: 2019 PMID: 30978173 PMCID: PMC6503883 DOI: 10.18632/aging.101899
Source DB: PubMed Journal: Aging (Albany NY) ISSN: 1945-4589 Impact factor: 5.682
Figure 1Exogenous biological renal support improved renal IRI and decreased mortality and serum Cr, BUN levels in old IRI mice. (A) Survival curves for the old IRI mice at 72 hours. (B) Cr levels in the old mice. (C) BUN levels in the old mice. (D) Representative photographs of kidney sections from the old mice stained with periodic acid–Schiff (400× magnification). (E) Renal tubular injury score. (F) The levels of Kim1 in kidney extracts from the old mice, as measured by western blotting. Gels were performed under the same experimental conditions. (G) Quantitative analyses of the band densities of Kim1 expression. Values are presented as means ± SDs. ▲P < 0.05, ▲▲P < 0.01 vs. O: sham; *P < 0.05, **P < 0.01 vs. O: IRI. BUN, blood urea nitrogen Cr, serum creatinine; SD, standard deviation.
Figure 2Exogenous biological renal support increased renal cell proliferation in old IRI mice. (A) Representative images of renal EdU-positive cells in independent groups (600× magnification; red, EDU; green, LTL; blue, DAPI). (B) The percentages of EdU-positive cells in the kidneys of the old mice at 72 hours after IRI. The mice in the O: IRI group displayed more EdU-positive cells than in O: sham group. The percentage of EdU-positive cells was higher in the O-O: IRI group and the Y-O: IRI group than in the O: IRI group. No significant difference was found between the O-O: IRI group and the Y-O: IRI group. (C) Representative images of renal PCNA-positive tubular cells in independent groups (400× magnification). (D) The percentages of PCNA-positive tubular cells in the kidneys of the old mice at 72 hours after IRI. The mice in the O: IRI group had more PCNA-positive tubular cells than the O: sham group. The percentages of PCNA-positive tubular cells were higher in the O-O: IRI group and the Y-O: IRI group than in the O: IRI group. No significant difference was found between the O-O: IRI group and the Y-O: IRI group. (E) The levels of cyclin D1 and cyclin E1 in kidney extracts of the old IRI mice as measured by western blotting. Gels were performed under the same experimental conditions. (F, G) Quantitative analyses of the band densities of cyclin D1 and cyclin E1 protein expression. Data are presented as means ± SDs. ▲P < 0.05, ▲▲P < 0.01 vs. O: sham; *P < 0.05, **P < 0.01 vs. O: IRI. SD, standard deviation.
Figure 3Exogenous biological renal support increased dedifferentiation in old IRI mice kidney. (A) The levels of Pax2, vimentin, and ERK1/2 in kidney extracts of the old IRI mice as measured by western blotting. Gels were performed under the same experimental conditions. (B–D) Quantitative analyses of the band densities of Pax2, vimentin, and ERK1/2 expressions. Data are presented as means ± SDs. ▲P < 0.05, ▲▲P < 0.01 vs. O: sham; *P < 0.05, **P < 0.01 vs. O: IRI. SD, standard deviation.
Figure 4The impact of serum cytokines on the prognosis of the old IRI mice. (A) The canonical serum cytokines between the O-O: IRI to the old: IRI group and the Y-O: IRI to the old: IRI group. (B) Heat map of the O-O: IRI to the old: IRI group. (C) Heat map of the Y-O: IRI to the old: IRI group. (D) Gene Ontology Annotation was used to identify the molecular function of the differentially expressed cytokines (E) Gene Ontology Annotation was used to identify the cellular components of the differentially expressed cytokines (F) Gene Ontology Annotation was used to identify the biological process of differentially expressed cytokines (G) The KEGG pathways that changed significantly were those related to differentially expressed cytokines. (H) The protein-protein interaction network among the differentially expressed cytokines.
Significant different protein identified by cluster analysis.
| IGF-1 | mmu:16000 | Insulin-like growth factor 1 | GH1 - growth hormone 1 | 3.081 | 3.395 |
| MDC (CCL22) | mmu:20299 | Macrophage-Derived Chemokine | CCL22 – Chemokine (C-C motif) ligand 22 | 2.3 | 2.481 |
| TPO | mmu:21832 | Thrombopoietin | MPL - Myeloproliferative leukemia virus oncogene | 8.293 | 18.206 |
| CD30L | mmu:21949 | Tumor Necrosis Factor (Ligand) Superfamily, Member 8 | TNFSF8 - Tumor necrosis factor (ligand) superfamily, | 10.864 | 8.485 |
| Eotaxin-1 (CCL11 | mmu:20292 | Eotaxin-1 | CCL11 - Chemokine (C-C motif) ligand 11 | 2.169 | 2.14 |
| GM-CSF | mmu:12983 | Colony Stimulating Factor 2 (Granulocyte-Macrophage) | CSF2 - Colony stimulating factor 2 | 2.253 | 2.176 |
| IFN-gamma | mmu:15978 | Interferon Gamma | JAK2 - Janus kinase 2 | 2.984 | 2.454 |
| IL-1alpha | mmu:16175 | Interleukin 1 Alpha | Interleukin 1 A | 2.751 | 2.739 |
| IL-1beta | mmu:16176 | Interleukin 1 Beta | Interleukin 1 B | 3.243 | 2.616 |
| IL-2 | mmu:16183 | Interleukin 2 | IL2 - Interleukin 2 | 2.079 | 1.633 |
| IL-3 | mmu:16187 | Interleukin 3 | IL3 - Interleukin 3 | 2.643 | 2.312 |
| IL-4 | mmu:16189 | Interleukin 4 | IL4 - Interleukin 4 | 2.544 | 2.226 |
| IL-5 | mmu:16191 | Interleukin 5 | IL5 - Interleukin 5 | 3.253 | 2.393 |
| IL-10 | mmu:16153 | Interleukin 10 | IL10 - Interleukin 10 | 2.335 | 1.871 |
| IL-12p40 | mmu:16160 | Interleukin 12B | IL12B | 3.691 | 3.335 |
| IL-17A | mmu:16171 | Interleukin 17A | Interleukin 17A | 3.605 | 2.86 |
| Leptin | mmu:16846 | Leptin | LEP – Leptin | 4.439 | 3.575 |
| MIP-1alpha | mmu:20302 | Macrophage Inflammatory Protein 1-Alpha | CCL3 - Chemokine (C-C motif) ligand 3 | 4.173 | 2.95 |
| TNF-alpha | mmu:21926 | TNF-Alpha | TNF - Tumor necrosis factor | 2.938 | 2.59 |
| E-Selectin | mmu:20339 | Selectin E | SELE - Selectin E | 0.636 | 0.661 |
| P-Selectin | mmu:20344 | Selectin P | SELP - Selectin P | 0.597 | 0.601 |
| Decorin | mmu:13179 | Decorin | DCN - Decorin | 0.604 | 0.628 |
| Pentraxin-3(TSG-14) | mmu:19288 | Pentraxin 3 | PTX3 - Pentraxin 3 | 0.522 | 0.248 |
| Prolactin | mmu:19109 | Prolactin | PRL - Prolactin | 0.015 | 0.117 |
Differentially expressed cytokines related pathway by PANTHER analysis.
| IGF-1 | mmu:16000 | P00033:Insulin/IGF pathway-protein kinase B signaling cascade; |
| Igf1 | P00032:Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP | |
| MDC | mmu:20299 | P00031:Inflammation mediated by chemokine and cytokine signaling pathway |
| (CCL22) | Ccl22 | |
| TPO | mmu:21832 | |
| Thpo | ||
| CD30L | mmu:21949 | |
| Tnfsf8 | ||
| Eotaxin-1 | mmu:20292 | P00031:Inflammation mediated by chemokine and cytokine signaling pathway |
| (CCL11) | Ccl11 | |
| GM-CSF | mmu:12983 | P00036:Interleukin signaling pathway |
| Csf2rb | ||
| IFN-gamma | mmu:15978 | P00035:Interferon-gamma signaling pathway; |
| Ifng | P00031:Inflammation mediated by chemokine and cytokine signaling pathway | |
| IL-1alpha | mmu:16175 | P00036:Interleukin signaling pathway |
| Il1a | ||
| IL-1beta | mmu:16176 | P00031:Inflammation mediated by chemokine and cytokine signaling pathway |
| Il1b | ||
| IL-2 | mmu:16183 | P00031:Inflammation mediated by chemokine and cytokine signaling pathway; |
| Il2 | P00036:Interleukin signaling pathway | |
| IL-3 | mmu:16187 | P00036:Interleukin signaling pathway |
| Il3 | ||
| IL-4 | mmu:16189 | P00036:Interleukin signaling pathway |
| Il4 | ||
| IL-5 | mmu:16191 | P00031:Inflammation mediated by chemokine and cytokine signaling pathway; |
| Il5 | P00036:Interleukin signaling pathway | |
| IL-10 | mmu:16153 | P00036:Interleukin signaling pathway |
| Il10 | ||
| IL-12p40 | mmu:16160 | |
| Il12b | ||
| IL-17A | mmu:16171 | P00031:Inflammation mediated by chemokine and cytokine signaling pathway; |
| Il17a | P00036:Interleukin signaling pathway | |
| Leptin | mmu:16846 | |
| Lep | ||
| MIP-1alpha(CCL3) | mmu:20302 | P00031:Inflammation mediated by chemokine and cytokine signaling pathway |
| Ccl3 | ||
| TNF-alpha | mmu:21926 | P00057:Wnt signaling pathway; |
| Tnf | P00006:Apoptosis signaling pathway | |
| E-Selectin | mmu:20339 | |
| Sele | ||
| P-Selectin | mmu:20344 | |
| Selp | ||
| Decorin | mmu:13179 | |
| Dcn | ||
| Pentraxin-3(TSG-14) | mmu:19288 | |
| Ptx3 | ||
| Prolactin | mmu:19109 | |
| Prl |